134 related articles for article (PubMed ID: 33725942)
1. Role of serum CXCL9 and CXCL13 in predicting infection after kidney transplant: A STROBE study.
Yan L; Li YM; Li Y; Bai YJ; Wan ZL; Fan JW; Luo LM; Wang LL; Shi YY
Medicine (Baltimore); 2021 Mar; 100(11):e24762. PubMed ID: 33725942
[TBL] [Abstract][Full Text] [Related]
2. Chemokine Profiles Are Affected in Serum of Patients with Acute Rejection of Kidney Allograft.
Krupickova L; Fialova M; Novotny M; Svachova V; Mezerova K; Cecrdlova E; Viklicky O; Striz I
Mediators Inflamm; 2021; 2021():5513690. PubMed ID: 33776571
[TBL] [Abstract][Full Text] [Related]
3. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression.
Yin X; Wang Z; Wu T; Ma M; Zhang Z; Chu Z; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
J Transl Med; 2019 Dec; 17(1):417. PubMed ID: 31836011
[TBL] [Abstract][Full Text] [Related]
4. Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma.
Müllegger RR; Means TK; Shin JJ; Lee M; Jones KL; Glickstein LJ; Luster AD; Steere AC
Infect Immun; 2007 Sep; 75(9):4621-8. PubMed ID: 17606602
[TBL] [Abstract][Full Text] [Related]
5. Pretransplant serum CXCL9 and CXCL10 levels fail to predict acute rejection in kidney transplant recipients receiving induction therapy.
Heidt S; Shankar S; Muthusamy AS; San Segundo D; Wood KJ
Transplantation; 2011 Apr; 91(8):e59-61. PubMed ID: 21475065
[No Abstract] [Full Text] [Related]
6. CXCL10 and CXCL13 Expression were highly up-regulated in peripheral blood mononuclear cells in acute rejection and poor response to anti-rejection therapy.
Mao Y; Wang M; Zhou Q; Jin J; Wang Y; Peng W; Wu J; Shou Z; Chen J
J Clin Immunol; 2011 Jun; 31(3):414-8. PubMed ID: 21191639
[TBL] [Abstract][Full Text] [Related]
7. Automated Urinary Chemokine Assays for Noninvasive Detection of Kidney Transplant Rejection: A Prospective Cohort Study.
Van Loon E; Tinel C; de Loor H; Bossuyt X; Callemeyn J; Coemans M; De Vusser K; Sauvaget V; Olivre J; Koshy P; Kuypers D; Sprangers B; Van Craenenbroeck AH; Vaulet T; Anglicheau D; Naesens M
Am J Kidney Dis; 2024 Apr; 83(4):467-476. PubMed ID: 37777058
[TBL] [Abstract][Full Text] [Related]
8. Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
Graver JC; Abdulahad W; van der Geest KSM; Heeringa P; Boots AMH; Brouwer E; Sandovici M
J Autoimmun; 2021 Sep; 123():102684. PubMed ID: 34237649
[TBL] [Abstract][Full Text] [Related]
9. Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection.
Jackson JA; Kim EJ; Begley B; Cheeseman J; Harden T; Perez SD; Thomas S; Warshaw B; Kirk AD
Am J Transplant; 2011 Oct; 11(10):2228-34. PubMed ID: 21812928
[TBL] [Abstract][Full Text] [Related]
10. Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant.
Neujahr DC; Perez SD; Mohammed A; Ulukpo O; Lawrence EC; Fernandez F; Pickens A; Force SD; Song M; Larsen CP; Kirk AD
Am J Transplant; 2012 Feb; 12(2):438-46. PubMed ID: 22151926
[TBL] [Abstract][Full Text] [Related]
11. CCL2, CXCL8, CXCL9 and CXCL10 serum levels increase with age but are not altered by treatment with hydroxychloroquine in patients with osteoarthritis of the knees.
Bonfante HL; Almeida CS; Abramo C; Grunewald STF; Levy RA; Teixeira HC
Int J Rheum Dis; 2017 Dec; 20(12):1958-1964. PubMed ID: 25955863
[TBL] [Abstract][Full Text] [Related]
12. Interferon-inducible chemokines reflect severity and progression in sarcoidosis.
Su R; Nguyen ML; Agarwal MR; Kirby C; Nguyen CP; Ramstein J; Darnell EP; Gomez AD; Ho M; Woodruff PG; Koth LL
Respir Res; 2013 Nov; 14(1):121. PubMed ID: 24199653
[TBL] [Abstract][Full Text] [Related]
13. Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection.
Schiffer L; Wiehler F; Bräsen JH; Gwinner W; Greite R; Kreimann K; Thorenz A; Derlin K; Teng B; Rong S; von Vietinghoff S; Haller H; Mengel M; Pape L; Lerch C; Schiffer M; Gueler F
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137652
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis.
Takeuchi M; Oh-I K; Suzuki J; Hattori T; Takeuchi A; Okunuki Y; Usui Y; Usui M
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1063-8. PubMed ID: 16505042
[TBL] [Abstract][Full Text] [Related]
16. CXCL9/CXCL10 angiostasis CXC-chemokines in parallel with the CXCL12 as an angiogenesis CXC-chemokine are variously expressed in pre-eclamptic-women and their neonates.
Darakhshan S; Hassanshahi G; Mofidifar Z; Soltani B; Karimabad MN
Pregnancy Hypertens; 2019 Jul; 17():36-42. PubMed ID: 31487653
[TBL] [Abstract][Full Text] [Related]
17. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.
Han JH; Suh CH; Jung JY; Nam JY; Kwon JE; Yim H; Kim HA
Arthritis Res Ther; 2015 Sep; 17(1):260. PubMed ID: 26385705
[TBL] [Abstract][Full Text] [Related]
18. CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis.
Arger NK; Ho ME; Allen IE; Benn BS; Woodruff PG; Koth LL
Respir Med; 2020 Jan; 161():105822. PubMed ID: 31783271
[TBL] [Abstract][Full Text] [Related]
19. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.
Karason K; Jernås M; Hägg DA; Svensson PA
BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
